<DOC>
	<DOCNO>NCT02220868</DOCNO>
	<brief_summary>The protocol study safety efficacy use sofosbuvir ribavirin treatment hepatitis c patient take stribild .</brief_summary>
	<brief_title>Sofosbuvir , Ribavirin , Treatment Chronic Hepatitis C Virus Genotype 1 HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir : A Pilot Study</brief_title>
	<detailed_description>The objective study evaluate safety , efficacy pharmacokinetics sofosbuvir 400mg daily plus ribavirin 1000-1200 mg daily HIV-infected patient fix dose co-formulation emtricitabine/tenofovir/cobicistat/elvitegravir ( Stribild ) .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Elvitegravir , Cobicistat , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>18 year age old Chronic HCV genotype 1 infection Receiving emtricitabine/tenofovir/cobicistat/elvitegravir least 8 week . CD4 count &gt; 200 cells/mm3 screen CD4 count &lt; 200 previous 12 week HIV RNA PCR &lt; 50 copies/ml screen HIV RNA PCR &gt; 200 copies/ml previous 12 week History integrase inhibitor resistance History integrase inhibitor failure Absolute neutrophil count 1500/mm3 ( Black/ African Americans &lt; 1200/mm3 Patients cirrhosis Platelet count 90,000 per cubic millimeter Hemoglobin level &lt; 11 gm/dl woman &lt; 12 gm/dl men Previous treatment DAA Hepatocellular carcinoma AFP &gt; 100 ng/mL hepatitis B virus ( HBsAg positive ) Evidence decompensated liver disease include , limited , history presence clinical ascites , bleed varix , hepatic encephalopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>HIV</keyword>
	<keyword>HCV</keyword>
	<keyword>DAA</keyword>
</DOC>